We serve Chemical Name:2-(sec-Butyl)cyclohexanone CAS:14765-30-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(sec-Butyl)cyclohexanone
CAS.NO:14765-30-1
Synonyms:2-sec-Butylcyclohexanone;2-(1-Methylpropyl)cyclohexanone;EINECS 238-830-2;2-butan-2-ylcyclohexan-1-one;MFCD00051454
Molecular Formula:C10H18O
Molecular Weight:154.24900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:76-78ºC8 mm Hg(lit.)
Density:0.915
Index of Refraction:n20/D 1.458(lit.)
PSA:17.07000
Exact Mass:154.13600
LogP:2.79180
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-sec-Butylcyclohexanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00051454 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00051454 Use and application,2-(1-Methylpropyl)cyclohexanone technical grade,usp/ep/jp grade.
Related News: A U.S. Senator, New Jersey Democrat Bob Menendez, called allegations of manufacturing irregularities and records tampering at the Branchburg plant troubling. Menendez has sponsored a bill calling for a non-partisan, independent COVID-19 Commission to examine the U.S. pandemic response, including government contracts with companies. 2-(sec-Butyl)cyclohexanone manufacturer This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them. 2-(sec-Butyl)cyclohexanone supplier It is frequently associated with the presence of blasts or leukemic cells in the marrow. 2-(sec-Butyl)cyclohexanone vendor In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. 2-(sec-Butyl)cyclohexanone factory Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.
